cn3
Friday, 25 November 2016
The Problem With Lilly Is the Problem With Pharma
Eli Lilly’s Alzheimer’s drug trial failure spotlights the industry’s main problem.
from WSJ.com: Markets http://ift.tt/2grEyBO
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment